HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesOmeprazole
Chemical structure of CAS 73590-58-6

Omeprazole

In Stock•Starting at $9 for 5 g•Purity ≥ 95%
CAS No.73590-58-6
MDL No.MFCD23135254
MFC17H19N3O3S
MW345.40
InChI KeySUBDBMMJDZJVOS-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 g98%$9In Stock
10 g98%$12In Stock
25 g98%$24In Stock
50 g98%$41In Stock
100 g98%$73In Stock
250 g98%$168In Stock
500 g95%+$261In Stock
1 kg98%$371In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

6-Methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole is a benzimidazole sulfoxide.

CAS No.73590-58-6
Product NameOmeprazole

Biological Targets

ATP4A·ATP4B

Associated Conditions

medullary thyroid gland carcinoma·MALT lymphoma·gastric cancer·peptic esophagitis·gastroesophageal reflux disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Leishmania plasma membrane Mg2+-ATPase is a H+/K+-antiporter involved in glucose symport. Studies with sealed ghosts and vesicles of opposite polarity.

The Journal of biological chemistry • Vol. 276, Issue 8 • 2001
PMID: 11087746DOI: 10.1074/jbc.M008469200

Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy.

Alimentary pharmacology & therapeutics • Vol. 15, Issue 1 • 2001
PMID: 11136280DOI: 10.1046/j.1365-2036.2001.00907.x

A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.

Alimentary pharmacology & therapeutics • Vol. 15, Issue 1 • 2001
PMID: 11136281DOI: 10.1046/j.1365-2036.2001.00895.x

Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.

Alimentary pharmacology & therapeutics • Vol. 15, Issue 1 • 2001
PMID: 11136282DOI: 10.1046/j.1365-2036.2001.00876.x

Documentation

Similar Products